The program for the 2017 Annual Meeting of the American Society for Radiation Oncology (ASTRO), Sept. 24-27 in San Diego, will feature advances in cancer research, including reports from phase II and III clinical trials. Studies that examine innovative treatments, such as immunotherapy, mental health influences on cancer outcomes, and optimal radiation dosing and sequencing, will also be presented at the largest meeting for the field of radiation oncology.

September 13, 2017 — Since announcing the integration of CareSelect Imaging with Epic's enterprise electronic health record (EHR), National Decision Support Co. (NDSC) has steadily expanded the reach of its CareSelect Platform into the market. Over 225 mutual clients have adopted NDSC's foundational imaging solution to power imaging stewardship initiatives and compliance with federal legislation.

September 13, 2017 — ClaroNav announced that it has received U.S. Food and Drug Administration (FDA) 510(K) clearance to market and sell NaviENT in the United States. NaviENT is an image-guided surgical navigation system, which helps ear-nose-and-throat (ENT) surgeons with identifying anatomic structures in the transnasal interventions. It enables surgeons to avoid complications and confidently make more informed decisions during FESS and skull base surgeries.

Nuance Communications Inc. announced that Citizens Medical Center, a critical access hospital in rural Kansas, has completed a hospital-wide deployment of Nuance solutions to reduce transcription costs and improve physician satisfaction, productivity and efficiency. The implementation includes Dragon Medical One, eScription RH, PowerMic Mobile and the PowerShare Network.

Matrix Analytics announced it will clinically validate its LungDirect deep learning and predictive analytics tools for pulmonary nodules. Matrix Analytics has already developed technology for the management of pulmonary nodules. This technology, leveraged with cloud computing and deep learning, will begin clinical validation later this month. The new tool applies an automated cancer classifier identified in conventional chest computed tomography (CT) images to LungDirect's advanced learning algorithms.

Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from Sept. 11 – 14, 2017, applying advanced technologies and deep clinical insights to address peripheral vascular needs. With the addition of its recent acquisition, Spectranetics, Philips will for the first time highlight its expanded portfolio of interventional X-ray systems, advanced catheters for measurement and therapy, clinical informatics and services, including its Philips Azurion image-guided therapy platform, intravascular ultrasound (IVUS), Phoenix atherectomy system and Spectranetics' Stellarex drug-coated balloon.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now